Overall, the results show that although both CD4 cell count and viral load are the surrogate markers of HIV progression, viral load is more powerful in monitoring progression of HIV/AIDS in patients on antiretroviral therapy than CD4 cell count. This evidence concerns the gene CD4 and AIDS.